Salipro invited to present at the Tumor Model Summit Nordics

Written By Lorena Galan

Are you attending the Tumor Model Summit next week (April 9-10th) in Stockholm, Sweden?

Please join us on Wednesday, the 9th of April as our CSO, Robin Löving, will take the stage to present the Salipro® platform and highlight the exciting advancements in developing antibodies against wild-type CXCR4. 

Be sure to say hi to our newest talent, Mia Abramsson who also will be there.

Find more information on the conference here: https://tumour-models-nordics.com/

Lorena Galan
Previous

New Research - Salipro® enabled to unveil Taurine Transporter Secrets & Anti-Aging Potential
Next

Press Release: Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs